Materiały źródłowe

• #1 Alcoholic Hepatitis: Diagnosis and Management – PubMed

  https://pubmed.ncbi.nlm.nih.gov/35426628/

  Alcoholic hepatitis is a clinical syndrome characterized by acute-onset jaundice and liver enzyme abnormalities in the setting of long-term heavy alcohol use. […] Diagnosis of alcoholic hepatitis is primarily clinical, based on a consensus definition from the National Institute on Alcohol Abuse and Alcoholism. […] Initial workup should include chest radiography and cultures of peritoneal fluid, blood, and urine. […] Laboratory-based prognostic scores, including Maddrey Discriminant Function and the Model for End-Stage Liver Disease, help determine disease severity and treatment options. […] Responsiveness to corticosteroid therapy should be evaluated using the Lille score on day 7 of treatment. […] Long-term follow-up should focus on abstinence from alcohol, management of underlying cirrhosis, and evaluation for liver transplantation if indicated. […] The presence of underlying cirrhosis and continued alcohol use negatively impact long-term prognosis.

• #2 Alcoholic-Associated Hepatitis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470217/

  Patients with severe alcoholic hepatitis with an MDF greater than 32 have 30-day mortality of 30% to 50%. […] To determine prognosis the following factors need to be considered: Histologically proven alcohol hepatitis, Serum bilirubin greater than 2.5 mg/dl, Serum albumin less than 2.5 g/dl, Prothrombin time more than 5 seconds. […] A liver biopsy is generally not required to make the diagnosis of alcoholic hepatitis, except in uncertain cases to delineate the etiology of the hepatic injury.

• #3 Severe alcoholic hepatitis-current concepts, diagnosis and treatment options

  https://www.wjgnet.com/1948-5182/full/v6/i10/688.htm

  Alcoholic hepatitis (AH) is an acute hepatic manifestation occurring from heavy alcohol ingestion. […] Despite the wide range of severity at presentation, those with severe ASH (Maddreys discriminant function 32) typically present with fever, jaundice, and abdominal tenderness. […] Thus, infection and renal failure have a major impact on survival and should be closely monitored in patients with severe ASH. […] Patients with severe ASH have a reported short-term mortality of up to 40%-50%. […] Severe ASH at risk of early death should be identified by one of the available prognostic scoring systems before considering specific therapies. […] Corticosteroids are the mainstay of treatment for severe ASH. […] The clinical syndrome of jaundice and liver function abnormalities in alcohol abusers is generally called AH, which has often been referred to as acute alcoholic hepatitis historically.

• #4 Alcoholic Hepatitis: Diagnosis and Management | AAFP

  https://www.aafp.org/pubs/afp/issues/2022/0400/p412.html

  High rates of concomitant infections, systemic inflammation, and multiorgan failure lead to significant morbidity and mortality. Diagnosis of alcoholic hepatitis is primarily clinical, based on a consensus definition from the National Institute on Alcohol Abuse and Alcoholism. […] The diagnosis is primarily clinical and must include acute-onset jaundice, specific laboratory abnormalities, and characteristic history of alcohol use (i.e., long-term consumption of roughly three standard drinks daily for women and four standard drinks daily for men). Liver biopsy is necessary only if the diagnosis is unclear and accurate diagnosis would impact management. […] Acute onset of jaundice is the only clinical sign or symptom required for the diagnosis of alcoholic hepatitis. […] The presence of the characteristic alcohol use history is an important component of the clinical diagnosis, and patient reluctance to disclose alcohol use is a significant issue.

• #5 Alcoholic Hepatitis: Diagnosis and Management – PubMed

  https://pubmed.ncbi.nlm.nih.gov/35426628/

  Alcoholic hepatitis is a clinical syndrome characterized by acute-onset jaundice and liver enzyme abnormalities in the setting of long-term heavy alcohol use. […] Diagnosis of alcoholic hepatitis is primarily clinical, based on a consensus definition from the National Institute on Alcohol Abuse and Alcoholism. […] Initial workup should include chest radiography and cultures of peritoneal fluid, blood, and urine. […] Laboratory-based prognostic scores, including Maddrey Discriminant Function and the Model for End-Stage Liver Disease, help determine disease severity and treatment options. […] Responsiveness to corticosteroid therapy should be evaluated using the Lille score on day 7 of treatment. […] Long-term follow-up should focus on abstinence from alcohol, management of underlying cirrhosis, and evaluation for liver transplantation if indicated. […] The presence of underlying cirrhosis and continued alcohol use negatively impact long-term prognosis.

• #6 Alcoholic Hepatitis vs. Alcoholic Fatty Liver Disease: Its Diagno

  https://www.longdom.org/open-access/alcoholic-hepatitis-vs-alcoholic-fatty-liver-disease-its-diagnosis-treatment-and-prognosis-98428.html

  A clinical syndrome known as alcoholic hepatitis (Alcoholic fatty liver disease) is characterised by acute-onset jaundice and abnormal liver enzyme levels when there has been prolonged heavy alcohol consumption. […] According to a consensus definition provided by the National Institute on alcohol abuse and Alcoholism, the diagnosis of alcoholic hepatitis is predominantly clinical. […] Chest radiography and cultures of peritoneal fluid, blood, and urine should be part of the initial workup. […] The National Institute on Alcohol Abuse and Alcoholism created a consensus statement for identifying the condition due to past diversity in alcoholic hepatitis diagnosis. In addition to acute-onset jaundice, specific laboratory abnormalities, and a recognisable history of alcohol use, the diagnosis is primarily clinical (i.e., long-term consumption of roughly three standard drinks daily for women and four standard drinks daily for men). Only when the diagnosis is ambiguous and a precise diagnosis may affect care is a liver biopsy required.

• #7 Alcoholic Liver Disease | Cleveland Clinic

  https://my.clevelandclinic.org/departments/digestive/medical-professionals/hepatology/alcoholic-liver-disease

  Fatty liver is usually diagnosed in the asymptomatic patient who is undergoing evaluation for abnormal liver function tests; typically, aminotransferase levels are less than twice the upper limit of normal. […] The diagnosis of alcoholic hepatitis is also based on a thorough history, physical examination, and review of laboratory tests. A recent consensus statement from the Alcoholic Hepatitis Consortium provided a working definition of alcoholic hepatitis that includes jaundice within 60 days of heavy consumption ( 50 g/day) of alcohol for a minimum of 6 months, serum bilirubin 3 mg/dL, elevated AST:ALT ratio 1.5 and no other obvious cause for hepatitis. […] The classic histologic features of alcoholic hepatitis include inflammation and necrosis, which are most prominent in the centrilobular region of the hepatic acinus.

• #8 Screening, Diagnosis, and Treatment of Alcohol-Related Liver Disease and Alcohol-Associated Hepatitis – Gastroenterology & Hepatology

  https://www.gastroenterologyandhepatology.net/archives/july-2022/screening-diagnosis-and-treatment-of-alcohol-related-liver-disease-and-alcohol-associated-hepatitis/

  ALD is defined as a clinical histopathologic spectrum ranging from steatosis, AH, and liver fibrosis ultimately leading to cirrhosis. […] As such, patients with significant alcohol use should be evaluated for possible ALD, which includes screening with serum liver tests and ultrasonography. […] In patients with ALD, transaminase levels are generally below 400 IU/L, with an elevated aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio. […] Even after taking a clinical history of a patient’s alcohol intake, differentiating between nonalcoholic fatty liver disease and ALD can remain challenging. […] Patients with AH can have a broad spectrum of presentation ranging from jaundice to liver failure. […] In symptomatic AH, patients typically present with jaundice, serum bilirubin levels greater than 3 mg/dL, and elevated transaminase levels (but typically <400 IU/L) with elevated AST to ALT ratio, and have consumed at least 1 alcoholic drink within 8 weeks of presentation of jaundice.

• #9 Alcoholic Hepatitis: Diagnosis and Management | AAFP

  https://www.aafp.org/pubs/afp/issues/2022/0400/p412.html

  High rates of concomitant infections, systemic inflammation, and multiorgan failure lead to significant morbidity and mortality. Diagnosis of alcoholic hepatitis is primarily clinical, based on a consensus definition from the National Institute on Alcohol Abuse and Alcoholism. […] The diagnosis is primarily clinical and must include acute-onset jaundice, specific laboratory abnormalities, and characteristic history of alcohol use (i.e., long-term consumption of roughly three standard drinks daily for women and four standard drinks daily for men). Liver biopsy is necessary only if the diagnosis is unclear and accurate diagnosis would impact management. […] Acute onset of jaundice is the only clinical sign or symptom required for the diagnosis of alcoholic hepatitis. […] The presence of the characteristic alcohol use history is an important component of the clinical diagnosis, and patient reluctance to disclose alcohol use is a significant issue.

• #10

  https://journals.lww.com/hep/fulltext/2020/01000/diagnosis_and_treatment_of_alcohol_associated.25.aspx

  There is no unique presentation of ALD that can be distinguished with confidence from other forms of liver disease. […] Alcohol use is often not disclosed by the affected patient, whereas liver injury, whether due to alcohol or other causes, often proceeds silently. […] Although not all patients with ALD meet the criteria for AUD, failure to recognize AUD remains a significant clinical problem. […] Providers need to have a high index of suspicion for AUD in patients presenting with nonspecific symptoms and signs given in Table 6. […] The role of liver biopsy is therefore to resolve diagnostic dilemmas and to establish consistency regarding AH in patients recruited to clinical trials. […] However, because uncertainty persists in a fair number of patients, a consensus statement regarding the clinical diagnosis of AH, and when biopsy confirmation of ASH was most valuable, was published in 2016.

• #11 Alcoholic Hepatitis

  https://mobile.fpnotebook.com/GI/Lvr/AlchlcHpts.htm

  Alcoholic Hepatitis Diagnostic findings […] Total Serum Bilirubin 3 mg/dl (51.3 uMol/L) […] Transaminase increase (Aspartate Aminotransferase, Alanine Aminotransferase) […] AST 50 U/L (0.83 ukat/L) AND […] AST/ALT 1.5 AND […] AST 400 U/L (6.68 ukat/L) AND […] ALT 400 U/L (6.68 ukat/L) […] […] […] Diagnosis […] Criteria (all must be present) […] No confounding factors (see below) […] Jaundice onset within prior 8 weeks […] Total Serum Bilirubin 3 mg/dl (51.3 uMol/L) […] Transaminase increase […] AST 50 U/L (0.83 ukat/L) AND […] AST/ALT 1.5 AND […] AST 400 U/L (6.68 ukat/L) AND […] ALT 400 U/L (6.68 ukat/L) […] Heavy Alcohol Use for 6 months (and 60 days of abstinence) before Jaundice onset […] Women with 3 standard drinks per day (40 g)

• #12 Screening, Diagnosis, and Treatment of Alcohol-Related Liver Disease and Alcohol-Associated Hepatitis – Gastroenterology & Hepatology

  https://www.gastroenterologyandhepatology.net/archives/july-2022/screening-diagnosis-and-treatment-of-alcohol-related-liver-disease-and-alcohol-associated-hepatitis/

  ALD is defined as a clinical histopathologic spectrum ranging from steatosis, AH, and liver fibrosis ultimately leading to cirrhosis. […] As such, patients with significant alcohol use should be evaluated for possible ALD, which includes screening with serum liver tests and ultrasonography. […] In patients with ALD, transaminase levels are generally below 400 IU/L, with an elevated aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio. […] Even after taking a clinical history of a patient’s alcohol intake, differentiating between nonalcoholic fatty liver disease and ALD can remain challenging. […] Patients with AH can have a broad spectrum of presentation ranging from jaundice to liver failure. […] In symptomatic AH, patients typically present with jaundice, serum bilirubin levels greater than 3 mg/dL, and elevated transaminase levels (but typically <400 IU/L) with elevated AST to ALT ratio, and have consumed at least 1 alcoholic drink within 8 weeks of presentation of jaundice.

• #13 Alcoholic Hepatitis

  https://mobile.fpnotebook.com/GI/Lvr/AlchlcHpts.htm

  Alcoholic Hepatitis Diagnostic findings […] Total Serum Bilirubin 3 mg/dl (51.3 uMol/L) […] Transaminase increase (Aspartate Aminotransferase, Alanine Aminotransferase) […] AST 50 U/L (0.83 ukat/L) AND […] AST/ALT 1.5 AND […] AST 400 U/L (6.68 ukat/L) AND […] ALT 400 U/L (6.68 ukat/L) […] […] […] Diagnosis […] Criteria (all must be present) […] No confounding factors (see below) […] Jaundice onset within prior 8 weeks […] Total Serum Bilirubin 3 mg/dl (51.3 uMol/L) […] Transaminase increase […] AST 50 U/L (0.83 ukat/L) AND […] AST/ALT 1.5 AND […] AST 400 U/L (6.68 ukat/L) AND […] ALT 400 U/L (6.68 ukat/L) […] Heavy Alcohol Use for 6 months (and 60 days of abstinence) before Jaundice onset […] Women with 3 standard drinks per day (40 g)

• #14 Diagnosis and Staging of Disease-Severity in Symptomatic Alcoholic Hepatitis | SpringerLink

  https://link.springer.com/chapter/10.1007/978-3-031-32483-3_65

  Alcoholic hepatitis should be suspected in patients with a recent onset of jaundice and with excessive chronic alcohol consumption. Diagnosis is based on clinical presentation and typical laboratory findings (AST/ALT ratio 1.5, AST 50 UI/L, AST and ALT 400 IU/L, total serum bilirubin 5 mg/dL). A liver biopsy is useful to confirm the diagnosis and exclude other diagnosis, but is not routinely performed in clinical practice in many centers. Different prognosis tools aiming to estimate the risk of short-time mortality and to determine whether the patients should be treated with a specific therapy, have been developed. The most used in clinical practice are the Maddrey discriminant function and the model for end-stage liver disease.

• #15 Tests for Alcohol-Induced Liver Disease | Stanford Health Care

  https://stanfordhealthcare.org/medical-conditions/liver-kidneys-and-urinary-system/alcohol-induced-liver-disease/diagnosis/liver-function-tests.html

  A series of special blood tests can often determine whether or not the liver is functioning properly. These tests can also distinguish between acute and chronic liver disorders and between hepatitis and cholestasis. […] The most commonly performed blood tests include the following: […] Alanine transaminase (ALT) test: This test measures the level of alanine aminotransferase (an enzyme found predominantly in the liver) that is released into the bloodstream after acute liver cell damage. This test may be performed to assess liver function, and/or to evaluate treatment of acute liver disease, such as hepatitis. […] Gamma-glutamyl transpeptidase test: This test measures the level of gamma-glutamyl transpeptidase (an enzyme that is produced in the liver, pancreas, and biliary tract). This test is often performed to assess liver function, to provide information about liver diseases, and to detect alcohol ingestion.

• #16 Alcoholic hepatitis: Challenges in diagnosis and management | MDedge

  https://mdedge.com/jfponline/article/106644/hepatology/alcoholic-hepatitis-challenges-diagnosis-and-management

  The diagnosis of alcoholic hepatitis is mainly clinical. In its usual presentation, jaundice develops rapidly in a person with a known history of heavy alcohol use. Other symptoms and signs may include ascites, encephalopathy, and fever. On examination, the liver may be enlarged and tender, and a hepatic bruit has been reported. […] Laboratory tests are important in evaluating potential alcoholic hepatitis, although no single laboratory marker can definitively establish alcohol as the cause of liver disease. To detect alcohol consumption, biochemical markers such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), mean corpuscular volume, carbohydrate-deficient transferrin, and, more commonly, gamma-glutamyl transpeptidase are used. […] Although alcoholic hepatitis can be suspected on the basis of clinical and biochemical clues, liver biopsy remains the gold standard diagnostic tool. It confirms the clinical diagnosis of alcoholic hepatitis in about 85% of all patients and in up to 95% when significant hyperbilirubinemia is present.

• #17 Tests for Alcohol-Induced Liver Disease | Stanford Health Care

  https://stanfordhealthcare.org/medical-conditions/liver-kidneys-and-urinary-system/alcohol-induced-liver-disease/diagnosis/liver-function-tests.html

  A series of special blood tests can often determine whether or not the liver is functioning properly. These tests can also distinguish between acute and chronic liver disorders and between hepatitis and cholestasis. […] The most commonly performed blood tests include the following: […] Alanine transaminase (ALT) test: This test measures the level of alanine aminotransferase (an enzyme found predominantly in the liver) that is released into the bloodstream after acute liver cell damage. This test may be performed to assess liver function, and/or to evaluate treatment of acute liver disease, such as hepatitis. […] Gamma-glutamyl transpeptidase test: This test measures the level of gamma-glutamyl transpeptidase (an enzyme that is produced in the liver, pancreas, and biliary tract). This test is often performed to assess liver function, to provide information about liver diseases, and to detect alcohol ingestion.

• #18 Screening, Diagnosis, and Treatment of Alcohol-Related Liver Disease and Alcohol-Associated Hepatitis – Gastroenterology & Hepatology

  https://www.gastroenterologyandhepatology.net/archives/july-2022/screening-diagnosis-and-treatment-of-alcohol-related-liver-disease-and-alcohol-associated-hepatitis/

  ALD is defined as a clinical histopathologic spectrum ranging from steatosis, AH, and liver fibrosis ultimately leading to cirrhosis. […] As such, patients with significant alcohol use should be evaluated for possible ALD, which includes screening with serum liver tests and ultrasonography. […] In patients with ALD, transaminase levels are generally below 400 IU/L, with an elevated aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio. […] Even after taking a clinical history of a patient’s alcohol intake, differentiating between nonalcoholic fatty liver disease and ALD can remain challenging. […] Patients with AH can have a broad spectrum of presentation ranging from jaundice to liver failure. […] In symptomatic AH, patients typically present with jaundice, serum bilirubin levels greater than 3 mg/dL, and elevated transaminase levels (but typically <400 IU/L) with elevated AST to ALT ratio, and have consumed at least 1 alcoholic drink within 8 weeks of presentation of jaundice.

• #19 Pulsenotes | Alcoholic hepatitis notes

  https://app.pulsenotes.com/medicine/hepatology/notes/alcoholic-hepatitis

  Alcoholic hepatitis is a clinical syndrome due to progressive alcohol-mediated liver inflammation and injury. […] Alcoholic hepatitis generally refers to the acute onset of symptomatic hepatitis due to heavy alcohol consumption. […] Characteristic clinical features and laboratory findings in the context of heavy alcohol consumption is usually enough to make a diagnosis of alcoholic hepatitis. […] A liver biopsy is usually reserved for severe cases of alcoholic hepatitis. […] A combination of clinical features and laboratory findings are used to make a diagnosis of alcoholic hepatitis. […] Laboratory features suggestive of alcoholic hepatitis include: Moderately elevated transaminases (300 IU/L), AST/ALT ratio 2, Elevated bilirubin (usually 86 umol/L), Elevated gamma-glutamyl transferase (GGT), Elevated neutrophil count (typically 20.0 x10^9/L), Elevated INR (usually due to impaired synthesis of coagulation factors with severe inflammation).

• #20 Alcoholic Hepatitis (Alcohol-Associated Hepatitis) Workup: Approach Considerations, Complete Blood Count, Screening Blood Tests

  https://emedicine.medscape.com/article/170539-workup

  The diagnosis of alcoholic hepatitis is straightforward and requires no further diagnostic studies in patients presenting with a history of alcohol abuse, typical symptoms and physical findings, evidence of liver functional impairment, and compatible liver enzyme levels. […] Studies have indicated that serum C-reactive protein (CRP) is an accurate marker of alcoholic hepatitis (ie, sensitivity, 41%; specificity, 99%; positive predictive value [PPV], 98%; negative predictive value [NPV], 88%). […] Imaging studies are rarely required for the diagnosis of alcoholic hepatitis, but they can be useful in excluding other causes of liver disease. […] Liver biopsy is not always required in the evaluation of alcoholic hepatitis, but it may be useful in establishing the diagnosis, in determining the presence or absence of cirrhosis, and in excluding other causes of liver disease.

• #21 Alcoholic Hepatitis (Alcohol-Associated Hepatitis) Workup: Approach Considerations, Complete Blood Count, Screening Blood Tests

  https://emedicine.medscape.com/article/170539-workup

  The diagnostic value of serum biomarkers, such as the Ash test (ie, the six components of the FibroTest-ActiTest plus AST), was tested and validated in 275 patients with alcoholic hepatitis. […] Carbohydrate-deficient transferrin is perhaps the most reliable marker of chronic alcoholism, irrespective of the presence of liver disease.

• #22 Alcohol-Related Liver Disease – Hepatic and Biliary Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/alcohol-related-liver-disease/alcohol-related-liver-disease

  Confirmed history of alcohol use. Alcohol biomarkers. Liver tests and complete blood count (CBC). Sometimes liver biopsy. […] Alcohol is suspected as the cause of liver disease in any patient who chronically consumes excess alcohol, particularly 80 g per day. Patients can be screened for alcohol use disorder using the CAGE questionnaire or AUDIT. When the patient’s alcohol consumption is in doubt, history can be confirmed by family members or alcohol biomarkers. Urine or hair ethyl glucuronide, urine ethyl sulfate, and phosphatidylethanol (PEth) are not affected by liver disease. […] There is no specific test for alcohol-related liver disease, but if the diagnosis is suspected, liver tests and CBC are done to detect signs of liver injury and anemia. […] Not all experts agree on the indications for liver biopsy. Proposed indications include unclear clinical diagnosis, clinical suspicion of one cause of liver disease, and desire for a precise prediction of prognosis. […] Liver biopsy confirms liver disease, helps identify excessive alcohol use as the likely cause, and establishes the stage of liver injury.

• #23 Screening, Diagnosis, and Treatment of Alcohol-Related Liver Disease and Alcohol-Associated Hepatitis – Gastroenterology & Hepatology

  https://www.gastroenterologyandhepatology.net/archives/july-2022/screening-diagnosis-and-treatment-of-alcohol-related-liver-disease-and-alcohol-associated-hepatitis/

  Although the severity of liver disease at the time of presentation is a major factor in determining short-term mortality in AH, long-term prognosis of AH and ALD depends on continued abstinence. […] The adverse effect of ongoing alcohol use on mortality in patients with ALD highlights the importance of AUD treatment, which can include inpatient alcohol rehabilitation, group therapy, individual therapy, and family or couples counseling. […] In addition, there are several medications that may be administered for relapse prevention. […] Both pharmacologic therapy and behavioral therapy have shown significant efficacy. […] Alcohol biomarkers can provide further objective information and support patients through recovery. […] The development of biomarkers has been pivotal in diagnosing and supporting recovery in patients with AUD and ALD.

• #24 Alcohol-Induced Hepatitis: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17853-alcoholic-hepatitis

  Your healthcare provider will begin by asking about your health history, including alcohol use. If they suspect an alcohol use disorder, they will examine you for signs of related organ damage. This may involve several tests, including: […] How is alcohol-induced hepatitis diagnosed? […] Blood tests. A complete blood count (CBC) screens for a variety of disorders, while liver function tests check specifically for elevated liver enzymes. Blood and urine (pee) alcohol screens, such as phosphatidyl ethanol and urine ethyl glucuronide, are becoming more common. […] Imaging tests to visualize your liver and look for signs of inflammation and damage, such as an ultrasound, FibroScan (where available), CT scan or MRI. […] Liver biopsy. Your healthcare provider may need to examine a sample of your liver tissue in the lab. Theyll take the sample through a hollow needle inserted into your liver.

• #25 Alcoholic Hepatitis (Alcohol-Associated Hepatitis) Workup: Approach Considerations, Complete Blood Count, Screening Blood Tests

  https://emedicine.medscape.com/article/170539-workup

  The diagnosis of alcoholic hepatitis is straightforward and requires no further diagnostic studies in patients presenting with a history of alcohol abuse, typical symptoms and physical findings, evidence of liver functional impairment, and compatible liver enzyme levels. […] Studies have indicated that serum C-reactive protein (CRP) is an accurate marker of alcoholic hepatitis (ie, sensitivity, 41%; specificity, 99%; positive predictive value [PPV], 98%; negative predictive value [NPV], 88%). […] Imaging studies are rarely required for the diagnosis of alcoholic hepatitis, but they can be useful in excluding other causes of liver disease. […] Liver biopsy is not always required in the evaluation of alcoholic hepatitis, but it may be useful in establishing the diagnosis, in determining the presence or absence of cirrhosis, and in excluding other causes of liver disease.

• #26 Alcoholic Hepatitis | Liver Care | Bon Secours

  https://www.bonsecours.com/health-care-services/liver-care-hepatology/conditions/alcoholic-hepatitis

  Alcoholic hepatitis is a liver infection that is caused by heavy drinking over time. Your specialist can diagnose alcoholic hepatitis using blood tests and imaging tests. […] Your specialist will use one or more of the following tests to diagnose alcoholic hepatitis: Physical examination – your doctor will ask about your health history, drinking habits and symptoms specific to alcoholic hepatitis. Your doctor will feel your abdomen to check for an enlarged liver or spleen. Abdominal computed tomography (CT) scan – this type of imaging test is a specialized X-ray that creates detailed images of your liver and surrounding body structures. Your specialist uses these images to determine the extent of liver damage. Liver biopsy – during this test, your provider inserts a thin needle into your abdomen near your liver and then removes a small tissue sample (biopsy) for close analysis in the lab. Lab technicians can determine if your liver has been damaged. Blood tests – your specialist may use blood tests such as a complete blood count (CBC) or blood clotting tests to confirm the diagnosis of alcoholic hepatitis. Liver function test – your specialist may order this type of blood test to check how well your liver is functioning. A liver function test measures the levels of proteins, bilirubin (byproduct of red blood cell breakdown) and liver enzymes in your blood. Ultrasound – this imaging test uses sound waves to create detailed images of the inside of your body. Your specialist can use this image to determine the extent of liver damage.

• #27 Alcoholic Hepatitis: Causes, Symptoms, and Diagnosis

  https://www.healthline.com/health/alcoholic-hepatitis

  If you have symptoms of alcoholic hepatitis, your doctor will ask you about your health history and alcohol consumption. Theyll also perform a physical exam to help determine if you have an enlarged liver or spleen. […] They may decide to order tests to help confirm the diagnosis. These tests could include: complete blood count (CBC), liver function test, blood clotting tests, abdominal CT scan, ultrasound of the liver. […] Your doctor may order a liver biopsy to confirm a diagnosis of alcoholic hepatitis. A liver biopsy requires your doctor to remove a tissue sample from the liver. Its an invasive procedure with certain inherent risks, but biopsy results can show the severity and type of liver condition.

• #28 Alcoholic Hepatitis: Diagnosis and Management | AAFP

  https://www.aafp.org/pubs/afp/issues/2022/0400/p412.html

  High rates of concomitant infections, systemic inflammation, and multiorgan failure lead to significant morbidity and mortality. Diagnosis of alcoholic hepatitis is primarily clinical, based on a consensus definition from the National Institute on Alcohol Abuse and Alcoholism. […] The diagnosis is primarily clinical and must include acute-onset jaundice, specific laboratory abnormalities, and characteristic history of alcohol use (i.e., long-term consumption of roughly three standard drinks daily for women and four standard drinks daily for men). Liver biopsy is necessary only if the diagnosis is unclear and accurate diagnosis would impact management. […] Acute onset of jaundice is the only clinical sign or symptom required for the diagnosis of alcoholic hepatitis. […] The presence of the characteristic alcohol use history is an important component of the clinical diagnosis, and patient reluctance to disclose alcohol use is a significant issue.

• #29 Alcoholic-Associated Hepatitis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470217/

  Patients with severe alcoholic hepatitis with an MDF greater than 32 have 30-day mortality of 30% to 50%. […] To determine prognosis the following factors need to be considered: Histologically proven alcohol hepatitis, Serum bilirubin greater than 2.5 mg/dl, Serum albumin less than 2.5 g/dl, Prothrombin time more than 5 seconds. […] A liver biopsy is generally not required to make the diagnosis of alcoholic hepatitis, except in uncertain cases to delineate the etiology of the hepatic injury.

• #30 Alcoholic hepatitis: Challenges in diagnosis and management | MDedge

  https://mdedge.com/jfponline/article/106644/hepatology/alcoholic-hepatitis-challenges-diagnosis-and-management

  The American Association for the Study of Liver Diseases (AASLD) recommends biopsy in patients who have a clinical diagnosis of severe alcoholic hepatitis for whom medical treatment is being considered and in those with an uncertain underlying diagnosis. […] Needed is a minimally invasive test for assessing this disease. Breath analysis might be such a test, offering a noninvasive means to study the composition of volatile organic compounds and elemental gases and an attractive method to evaluate health and disease in a patient-friendly manner. Our group devised a model based on breath levels of trimethylamine and pentane. When we tested it, we found that it distinguishes patients with alcoholic hepatitis from those with acute liver decompensation from causes other than alcohol and controls without liver disease with up to 90% sensitivity and 80% specificity.

• #31 Alcohol-associated hepatitis – Knowledge @ AMBOSS

  https://www.amboss.com/us/knowledge/alcohol-associated-hepatitis/

  Indications for liver biopsy include unclear diagnosis because of the presence of confounding factors, uncertain alcohol consumption, and recruitment to a clinical trial. […] Prognostic scoring systems are used to guide management and determine disease severity. Severe alcohol-associated hepatitis is defined as MELD score 20. […] Liver transplantation should be considered in selected patients with acute alcohol-associated hepatitis, even if they have not abstained from alcohol for the required 6 months.

• #32 Alcoholic hepatitis: Challenges in diagnosis and management | MDedge

  https://mdedge.com/jfponline/article/106644/hepatology/alcoholic-hepatitis-challenges-diagnosis-and-management

  The diagnosis of alcoholic hepatitis is mainly clinical. In its usual presentation, jaundice develops rapidly in a person with a known history of heavy alcohol use. Other symptoms and signs may include ascites, encephalopathy, and fever. On examination, the liver may be enlarged and tender, and a hepatic bruit has been reported. […] Laboratory tests are important in evaluating potential alcoholic hepatitis, although no single laboratory marker can definitively establish alcohol as the cause of liver disease. To detect alcohol consumption, biochemical markers such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), mean corpuscular volume, carbohydrate-deficient transferrin, and, more commonly, gamma-glutamyl transpeptidase are used. […] Although alcoholic hepatitis can be suspected on the basis of clinical and biochemical clues, liver biopsy remains the gold standard diagnostic tool. It confirms the clinical diagnosis of alcoholic hepatitis in about 85% of all patients and in up to 95% when significant hyperbilirubinemia is present.

• #33 Alcoholic Liver Disease | Cleveland Clinic

  https://my.clevelandclinic.org/departments/digestive/medical-professionals/hepatology/alcoholic-liver-disease

  Fatty liver is usually diagnosed in the asymptomatic patient who is undergoing evaluation for abnormal liver function tests; typically, aminotransferase levels are less than twice the upper limit of normal. […] The diagnosis of alcoholic hepatitis is also based on a thorough history, physical examination, and review of laboratory tests. A recent consensus statement from the Alcoholic Hepatitis Consortium provided a working definition of alcoholic hepatitis that includes jaundice within 60 days of heavy consumption ( 50 g/day) of alcohol for a minimum of 6 months, serum bilirubin 3 mg/dL, elevated AST:ALT ratio 1.5 and no other obvious cause for hepatitis. […] The classic histologic features of alcoholic hepatitis include inflammation and necrosis, which are most prominent in the centrilobular region of the hepatic acinus.

• #34 Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis – Sharma – Translational Gastroenterology and Hepatology

  https://tgh.amegroups.org/article/view/5544/html

  Liver biopsy if done shows macrovesicular steatosis, fibrosis or cirrhosis or combination of these findings. […] The diagnosis of AH can be made with good sensitivity and specificity thorough good reliable history, physical examination, and laboratory results. […] Liver biopsy is confirmatory if diagnosis is in doubt, but generally not required in day to day management of these patients. […] Liver biopsy will show neutrophil predominant inflammatory infiltrate, Mallory hyaline, ballooned hepatocytes and varied degree of fibrosis or cirrhosis as overlap of these pathological findings are common. […] Liver biopsy is normally not required for the confirmation of alcoholic cirrhosis. […] However, if there is any doubt, no definitive history of significant alcohol intake in the recent past, associated AH which require steroid treatment or associated co infection with viral disease, one may need to do transjugular liver biopsy for proper evaluation of aetiology of liver cirrhosis. […] Liver biopsy is generally not required in majority of patients except when history of alcohol intake is not reliable, associated infection with viral disease, obesity or other hepatotropic or non-hepatotropic insult and treatment protocols under trials when definitive diagnosis of AH is required.

• #35 Diagnosis of alcoholic liver disease

  https://www.wjgnet.com/1007-9327/full/v20/i33/11684.htm

  The diagnosis of ALD can generally be made based on history, clinical and laboratory findings. […] However, the diagnosis of ALD can be clinically challenging as there is no single diagnostic test that confirms the diagnosis and patients may not be forthcoming about their degree of alcohol consumption. […] In addition, clinical findings may be absent or minimal in early ALD characterized by hepatic steatosis. […] Typical laboratory findings in ALD include transaminase levels with aspartate aminotransferase greater than alanine aminotransferase as well as increased mean corpuscular volume, gamma-glutamyltranspeptidase, and IgA to IgG ratio. […] In unclear cases, the diagnosis can be supported by imaging and liver biopsy. […] The histological features of ALD can ultimately define the diagnosis according to the typical presence and distribution of hepatic steatosis, inflammation, and Mallory-Denk bodies. […] Because of the potential reversible nature of ALD with sobriety, regular screening of the general population and early diagnosis are essential.

• #36 Alcoholic Hepatitis: Diagnosis and Management | AAFP

  https://www.aafp.org/pubs/afp/issues/2022/0400/p412.html

  Because of significant overlap in presenting symptoms of alcoholic hepatitis and other diagnoses, a thorough history, laboratory studies, and imaging tests should be performed to rule out confounding and concomitant diagnoses. […] After establishing the diagnosis of alcoholic hepatitis, clinicians should use validated laboratory-based prognostic tools to determine severity, prognosis, and treatment options. Severe alcoholic hepatitis is defined as a score of at least 32 using the Maddrey Discriminant Function tool or at least 21 using the Model for End-Stage Liver Disease tool. […] Guidelines support initiating oral corticosteroids in patients with severe alcoholic hepatitis. However, the benefit of corticosteroids is questionable, and treatment should be limited to 28 days. […] Corticosteroid use should be discontinued in patients who do not show an initial response.

• #37 Alcoholic Hepatitis: Diagnosis and Management – PubMed

  https://pubmed.ncbi.nlm.nih.gov/35426628/

  Alcoholic hepatitis is a clinical syndrome characterized by acute-onset jaundice and liver enzyme abnormalities in the setting of long-term heavy alcohol use. […] Diagnosis of alcoholic hepatitis is primarily clinical, based on a consensus definition from the National Institute on Alcohol Abuse and Alcoholism. […] Initial workup should include chest radiography and cultures of peritoneal fluid, blood, and urine. […] Laboratory-based prognostic scores, including Maddrey Discriminant Function and the Model for End-Stage Liver Disease, help determine disease severity and treatment options. […] Responsiveness to corticosteroid therapy should be evaluated using the Lille score on day 7 of treatment. […] Long-term follow-up should focus on abstinence from alcohol, management of underlying cirrhosis, and evaluation for liver transplantation if indicated. […] The presence of underlying cirrhosis and continued alcohol use negatively impact long-term prognosis.

• #38 Alcoholic hepatitis: Challenges in diagnosis and management | MDedge

  https://mdedge.com/jfponline/article/106644/hepatology/alcoholic-hepatitis-challenges-diagnosis-and-management

  Several models have been developed to assess the severity of alcoholic hepatitis and guide treatment decisions. The MDF (Maddrey Discriminant Function) system was the first scoring system developed and is still the most widely used. A score of 32 or higher indicates severe alcoholic hepatitis and has been used as the threshold for starting treatment with corticosteroids. […] The MELD (Model for End-stage Liver Disease) score. Sheth et al compared the MELD and the MDF scores in assessing the severity of alcoholic hepatitis. They found that the MELD performed as well as the MDF in predicting 30-day mortality. […] The GAHS (Glasgow Alcoholic Hepatitis Score) was shown to identify patients with alcoholic hepatitis who have an especially poor prognosis and need corticosteroid therapy. […] The Lille score. While the above scores are used to identify patients at risk of death from alcoholic hepatitis and to decide on starting corticosteroids, the Lille score is designed to assess response to corticosteroids after 1 week of treatment.

• #39 Screening, Diagnosis, and Treatment of Alcohol-Related Liver Disease and Alcohol-Associated Hepatitis – Gastroenterology & Hepatology

  https://www.gastroenterologyandhepatology.net/archives/july-2022/screening-diagnosis-and-treatment-of-alcohol-related-liver-disease-and-alcohol-associated-hepatitis/

  Prior to making a diagnosis of AH, other causes of liver disease, biliary obstruction, and hepatocellular carcinoma should be ruled out. […] Although symptomatic patients with AH can be identified by these criteria, liver biopsy may be needed in uncertain cases. […] Several scoring systems have been developed to classify the severity of a patient’s AH and guide treatment choices. […] Scoring systems such as Maddrey Discriminant Function (DF), Model for End-Stage Liver Disease (MELD), ABIC (age, serum bilirubin, international normalized ratio, creatinine) score, and Glasgow Alcoholic Hepatitis Score (GAHS) use these laboratory parameters to predict short-term mortality with great accuracy and help guide treatment decisions for patients with severe disease. […] The DF was first published in 1978 and is currently used to guide initiation of corticosteroids in patients with severe AH. […] Despite the multitude of scores that are available, the AASLD only recommends using the DF and MELD score to guide initiation of corticosteroids.

• #40 Pulsenotes | Alcoholic hepatitis notes

  https://app.pulsenotes.com/medicine/hepatology/notes/alcoholic-hepatitis

  The clinical and laboratory features of alcoholic hepatitis are similar to decompensated cirrhosis. […] Several models are available to determine the severity of alcoholic hepatitis. […] The Maddrey discriminant function (DF), Model for End-stage Liver Disease (MELD) and Glasgow alcoholic hepatitis score (GAH) can all be used to assess the severity of alcoholic hepatitis. […] Determining severity of alcoholic hepatitis is important to highlight patients with poor short-term survival and those who would benefit from pharmacological intervention. […] Severe alcoholic hepatitis is defined as a DF score 32. […] A score 9 is consistent with severe alcoholic hepatitis and associated with a poor 28-day and 84-day survival (46% and 40%, respectively).

• #41 Severe alcoholic hepatitis-current concepts, diagnosis and treatment options

  https://www.wjgnet.com/1948-5182/full/v6/i10/688.htm

  However, it is not much well-known which patients with ASH will progress to clinically evident AH. […] Several prognostic scoring systems, to date, have been developed and validated for use in those with AH. […] The best way to reverse alcohol-induced ACLF is to detect and control severe ASH as early as possible, which is less likely to recover spontaneously. […] There are several disease-specific prognostic models (MDF: Maddreys Discriminant Function; GAHS: Glasgow Alcoholic Hepatitis Score; ABIC: Age-Bilirubin-INR-Creatinine Score; Lille model; MAGIC: Model for Alcoholic hepatitis to Grade the severity In an Asian patient Cohort,) and a non-disease-specific model (MELD: Model for End-Stage Liver Disease). […] MDF is still one of the most commonly used prognostic models to predict survival outcomes in patients with ASH with 32 of a cutoff value.

• #42 Severe alcoholic hepatitis-current concepts, diagnosis and treatment options

  https://www.wjgnet.com/1948-5182/full/v6/i10/688.htm

  In patients with severe AH, renal impairment is a frequently accompanied symptom during hospitalization and also represents an important predictor of infection and survival. […] Specific therapies are indicated for patients with severe AH (MDF 32) who are at high risk of early death according to clinical prognostic scores. […] The impact of corticosteroid treatment on survival in those with severe AH has been under debate for the last three decades because of heterogeneity of the study design among different studies and selection bias from ambiguous diagnostic criteria lacking histologic confirmation. […] The Lille model now allows the early identification of non-responders to steroids, only 25% of whom being alive at 6 mo. […] Recently, an early LT concept was suggested to those with a first episode of severe ASH not responding to steroids. […] To settle the aforementioned issues, we are increasingly encouraged to conduct multi-center collaborative trials that use common protocols, include biomarkers, and address the spectrum of AH.

• #43 Alcoholic Hepatitis: Diagnosis and Management | AAFP

  https://www.aafp.org/pubs/afp/issues/2022/0400/p412.html

  Because of significant overlap in presenting symptoms of alcoholic hepatitis and other diagnoses, a thorough history, laboratory studies, and imaging tests should be performed to rule out confounding and concomitant diagnoses. […] After establishing the diagnosis of alcoholic hepatitis, clinicians should use validated laboratory-based prognostic tools to determine severity, prognosis, and treatment options. Severe alcoholic hepatitis is defined as a score of at least 32 using the Maddrey Discriminant Function tool or at least 21 using the Model for End-Stage Liver Disease tool. […] Guidelines support initiating oral corticosteroids in patients with severe alcoholic hepatitis. However, the benefit of corticosteroids is questionable, and treatment should be limited to 28 days. […] Corticosteroid use should be discontinued in patients who do not show an initial response.

• #44 Alcoholic-Associated Hepatitis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470217/

  Patients with severe alcoholic hepatitis with an MDF greater than 32 have 30-day mortality of 30% to 50%. […] To determine prognosis the following factors need to be considered: Histologically proven alcohol hepatitis, Serum bilirubin greater than 2.5 mg/dl, Serum albumin less than 2.5 g/dl, Prothrombin time more than 5 seconds. […] A liver biopsy is generally not required to make the diagnosis of alcoholic hepatitis, except in uncertain cases to delineate the etiology of the hepatic injury.

• #45 Alcoholic Hepatitis: Diagnosis and Management | AAFP

  https://www.aafp.org/pubs/afp/issues/2022/0400/p412.html

  Because of significant overlap in presenting symptoms of alcoholic hepatitis and other diagnoses, a thorough history, laboratory studies, and imaging tests should be performed to rule out confounding and concomitant diagnoses. […] After establishing the diagnosis of alcoholic hepatitis, clinicians should use validated laboratory-based prognostic tools to determine severity, prognosis, and treatment options. Severe alcoholic hepatitis is defined as a score of at least 32 using the Maddrey Discriminant Function tool or at least 21 using the Model for End-Stage Liver Disease tool. […] Guidelines support initiating oral corticosteroids in patients with severe alcoholic hepatitis. However, the benefit of corticosteroids is questionable, and treatment should be limited to 28 days. […] Corticosteroid use should be discontinued in patients who do not show an initial response.

• #46 Alcoholic-Associated Hepatitis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470217/

  Recent studies indicate that CRP is a good marker of alcoholic hepatitis. […] Abstinence along with adequate nutritional support remains the cornerstone of the management of patients with alcoholic hepatitis. […] Patients with AH are subdivided into mild-moderate AH or severe AH. […] Patients with severe AH with or without hepatic encephalopathy are considered candidates for a short course of prednisolone (40 mg/day for 28 days). […] The combination of systemic illness, malnutrition, concurrent renal injury, infections, lack of response to glucocorticoids or pentoxifylline result in poorer outcomes in severe alcoholic hepatitis. […] The differential diagnoses of alcoholic hepatitis include nonalcoholic steatohepatitis, acute or chronic viral hepatitis, drug-induced liver injury, fulminant Wilson disease, autoimmune liver disease, alpha-1 antitrypsin deficiency, pyogenic hepatic abscess, ascending cholangitis, or decompensation associated with hepatocellular carcinoma.

• #47 Alcoholic Hepatitis (Alcohol-Associated Hepatitis) Differential Diagnoses

  https://emedicine.medscape.com/article/170539-differential

  Common considerations in patients with alcoholism who have jaundice include chronic pancreatitis with biliary strictures and pancreaticobiliary neoplasms. […] Changes in the mental status of patients with alcoholic hepatitis do not always imply the presence of hepatic encephalopathy. Other conditions (eg, subdural hematomas) should be excluded by obtaining a computed tomography (CT) scan of the brain. […] The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease. […] Use of serum carbohydrate-deficient transferrin values to exclude alcoholic hepatitis from non-alcoholic steatohepatitis: a pilot study.

• #48 Alcohol-associated hepatitis – Knowledge @ AMBOSS

  https://www.amboss.com/us/knowledge/alcohol-associated-hepatitis/

  The presence of systemic inflammatory response syndrome (SIRS) criteria at admission is a predictor of multiorgan failure (especially AKI) and early death. Infections are common in patients with alcohol-associated hepatitis and are associated with a poorer prognosis. An infectious disease workup is recommended in all patients. […] Clinical diagnosis of alcohol-associated hepatitis includes onset of jaundice within the past 8 weeks and 6 months of ongoing alcohol consumption above the threshold and of abstinence from alcohol before jaundice onset. […] Obtain additional studies to exclude differential diagnoses and identify comorbidities; workup should be guided by clinical suspicion and may include the following: Infection, Autoimmune hepatitis, Metabolic liver disease, Drug-induced liver injury, Metabolic dysfunction-associated steatotic liver disease (MASLD).

• #49 Alcoholic Hepatitis: Diagnosis and Management – PubMed

  https://pubmed.ncbi.nlm.nih.gov/35426628/

  Alcoholic hepatitis is a clinical syndrome characterized by acute-onset jaundice and liver enzyme abnormalities in the setting of long-term heavy alcohol use. […] Diagnosis of alcoholic hepatitis is primarily clinical, based on a consensus definition from the National Institute on Alcohol Abuse and Alcoholism. […] Initial workup should include chest radiography and cultures of peritoneal fluid, blood, and urine. […] Laboratory-based prognostic scores, including Maddrey Discriminant Function and the Model for End-Stage Liver Disease, help determine disease severity and treatment options. […] Responsiveness to corticosteroid therapy should be evaluated using the Lille score on day 7 of treatment. […] Long-term follow-up should focus on abstinence from alcohol, management of underlying cirrhosis, and evaluation for liver transplantation if indicated. […] The presence of underlying cirrhosis and continued alcohol use negatively impact long-term prognosis.

• #50 06. Acute Alcoholic Hepatitis | Hospital Handbook

  https://hospitalhandbook.ucsf.edu/06-acute-alcoholic-hepatitis/06-acute-alcoholic-hepatitis

  Ensure MELD labs are sent (LFTs, BMP, INR, and albumin) in addition to CBC and infectious workup (CXR, blood, and urine cultures). […] In one series, clinical diagnosis of alcoholic hepatitis based upon HP, labs, and imaging was approximately 91% sensitive and 96% specific with 88% PPV. […] Poor prognostic indicators (severe AH): MDF 32 (predicts 1-month mortality of 20-50% with 86% sensitivity, 48% specificity). […] For patients with severe AH (MDF 32 or MELD 20), consider prednisolone 40mg daily if no contraindication. […] Sustained abstinence from alcohol is the mainstay of therapy.

• #51 Alcohol-associated hepatitis – Knowledge @ AMBOSS

  https://www.amboss.com/us/knowledge/alcohol-associated-hepatitis/

  The presence of systemic inflammatory response syndrome (SIRS) criteria at admission is a predictor of multiorgan failure (especially AKI) and early death. Infections are common in patients with alcohol-associated hepatitis and are associated with a poorer prognosis. An infectious disease workup is recommended in all patients. […] Clinical diagnosis of alcohol-associated hepatitis includes onset of jaundice within the past 8 weeks and 6 months of ongoing alcohol consumption above the threshold and of abstinence from alcohol before jaundice onset. […] Obtain additional studies to exclude differential diagnoses and identify comorbidities; workup should be guided by clinical suspicion and may include the following: Infection, Autoimmune hepatitis, Metabolic liver disease, Drug-induced liver injury, Metabolic dysfunction-associated steatotic liver disease (MASLD).

• #52 Alcoholic hepatitis: Challenges in diagnosis and management | MDedge

  https://mdedge.com/jfponline/article/106644/hepatology/alcoholic-hepatitis-challenges-diagnosis-and-management

  The American Association for the Study of Liver Diseases (AASLD) recommends biopsy in patients who have a clinical diagnosis of severe alcoholic hepatitis for whom medical treatment is being considered and in those with an uncertain underlying diagnosis. […] Needed is a minimally invasive test for assessing this disease. Breath analysis might be such a test, offering a noninvasive means to study the composition of volatile organic compounds and elemental gases and an attractive method to evaluate health and disease in a patient-friendly manner. Our group devised a model based on breath levels of trimethylamine and pentane. When we tested it, we found that it distinguishes patients with alcoholic hepatitis from those with acute liver decompensation from causes other than alcohol and controls without liver disease with up to 90% sensitivity and 80% specificity.

• #53

  https://journals.lww.com/hep/fulltext/2020/01000/diagnosis_and_treatment_of_alcohol_associated.25.aspx

  The statement was intended to improve consistency in diagnosis of AH across research studies and clinical trials, and to guide clinical decision making about the use of potentially toxic medications such as corticosteroids. […] Noninvasive tests for AH are sorely needed. […] A study of a panel of serum biomarkers of liver injury and inflammation in patients with AH demonstrated that circulating fragments of cytokeratin18 (CK18) and the main constituent of MalloryDenk bodies, termed M65 and M30, both had an area under the receiver operating characteristic curve (AUROC) of 0.84 to estimate the presence of AH. […] These data suggest that we may have biomarkers that have diagnostic significance for AH soon. […] At present, none of these have been adequately validated for routine clinical use in the diagnosis of AH. […] The diagnosis of AH (definite, probable, possible) should be made using the published consensus criteria.

• #54 Alcoholic Hepatitis (Alcohol-Associated Hepatitis) Workup: Approach Considerations, Complete Blood Count, Screening Blood Tests

  https://emedicine.medscape.com/article/170539-workup

  The diagnostic value of serum biomarkers, such as the Ash test (ie, the six components of the FibroTest-ActiTest plus AST), was tested and validated in 275 patients with alcoholic hepatitis. […] Carbohydrate-deficient transferrin is perhaps the most reliable marker of chronic alcoholism, irrespective of the presence of liver disease.

• #55 Diagnosis of alcoholic liver disease

  https://www.wjgnet.com/1007-9327/full/v20/i33/11684.htm

  The diagnosis of ALD can generally be made based on history, clinical and laboratory findings. […] However, the diagnosis of ALD can be clinically challenging as there is no single diagnostic test that confirms the diagnosis and patients may not be forthcoming about their degree of alcohol consumption. […] In addition, clinical findings may be absent or minimal in early ALD characterized by hepatic steatosis. […] Typical laboratory findings in ALD include transaminase levels with aspartate aminotransferase greater than alanine aminotransferase as well as increased mean corpuscular volume, gamma-glutamyltranspeptidase, and IgA to IgG ratio. […] In unclear cases, the diagnosis can be supported by imaging and liver biopsy. […] The histological features of ALD can ultimately define the diagnosis according to the typical presence and distribution of hepatic steatosis, inflammation, and Mallory-Denk bodies. […] Because of the potential reversible nature of ALD with sobriety, regular screening of the general population and early diagnosis are essential.

• #56 Screening, Diagnosis, and Treatment of Alcohol-Related Liver Disease and Alcohol-Associated Hepatitis – Gastroenterology & Hepatology

  https://www.gastroenterologyandhepatology.net/archives/july-2022/screening-diagnosis-and-treatment-of-alcohol-related-liver-disease-and-alcohol-associated-hepatitis/

  Abstract: Alcohol-related liver disease is a spectrum of disease in which continued, significant alcohol use can cause progression from fatty changes in the liver to inflammation, fibrosis, and eventually cirrhosis. […] As a result, clinicians must understand and implement screening tools for early diagnosis and remain up-to-date with the evolving nature of treatment options. […] This article reviews the diagnosis and treatment of alcohol use disorder as well as the pathophysiology, clinical presentation, and treatment of alcohol-related liver disease, including alcohol-associated hepatitis. […] Screening for and assessing the level of alcohol use in patients before the development of ALD is of utmost importance. […] This is best accomplished by obtaining a detailed history of alcohol consumption, which can be limited by underreporting.

• #57 Screening, Diagnosis, and Treatment of Alcohol-Related Liver Disease and Alcohol-Associated Hepatitis – Gastroenterology & Hepatology

  https://www.gastroenterologyandhepatology.net/archives/july-2022/screening-diagnosis-and-treatment-of-alcohol-related-liver-disease-and-alcohol-associated-hepatitis/

  The National Institute on Alcohol Abuse and Alcoholism recommends a single-question screen of “How many times in the past year have you had 5 or more drinks in a day (for men) or 4 or more drinks in a day (for women)?” […] If 1 or more episode is reported, further questioning using the Alcohol Use Disorders Identification Test (AUDIT) is recommended. […] Completion of AUDIT, however, can be time-consuming for both providers and patients. […] Additionally, screening for psychiatric comorbidities and abuse of other substances is essential, as these have been shown to occur at higher rates in patients with AUD and can have important implications for maintenance of abstinence and improving long-term outcomes. […] In a study of more than 10,000 patients with AUD, 47% reported anxiety, 43% reported depression, and 17% reported psychiatric comorbidities.

• #58 Alcohol-Induced Hepatitis: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17853-alcoholic-hepatitis

  Your healthcare provider will begin by asking about your health history, including alcohol use. If they suspect an alcohol use disorder, they will examine you for signs of related organ damage. This may involve several tests, including: […] How is alcohol-induced hepatitis diagnosed? […] Blood tests. A complete blood count (CBC) screens for a variety of disorders, while liver function tests check specifically for elevated liver enzymes. Blood and urine (pee) alcohol screens, such as phosphatidyl ethanol and urine ethyl glucuronide, are becoming more common. […] Imaging tests to visualize your liver and look for signs of inflammation and damage, such as an ultrasound, FibroScan (where available), CT scan or MRI. […] Liver biopsy. Your healthcare provider may need to examine a sample of your liver tissue in the lab. Theyll take the sample through a hollow needle inserted into your liver.

• #59 Alcohol-Related Liver Disease – Hepatic and Biliary Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/alcohol-related-liver-disease/alcohol-related-liver-disease

  Confirmed history of alcohol use. Alcohol biomarkers. Liver tests and complete blood count (CBC). Sometimes liver biopsy. […] Alcohol is suspected as the cause of liver disease in any patient who chronically consumes excess alcohol, particularly 80 g per day. Patients can be screened for alcohol use disorder using the CAGE questionnaire or AUDIT. When the patient’s alcohol consumption is in doubt, history can be confirmed by family members or alcohol biomarkers. Urine or hair ethyl glucuronide, urine ethyl sulfate, and phosphatidylethanol (PEth) are not affected by liver disease. […] There is no specific test for alcohol-related liver disease, but if the diagnosis is suspected, liver tests and CBC are done to detect signs of liver injury and anemia. […] Not all experts agree on the indications for liver biopsy. Proposed indications include unclear clinical diagnosis, clinical suspicion of one cause of liver disease, and desire for a precise prediction of prognosis. […] Liver biopsy confirms liver disease, helps identify excessive alcohol use as the likely cause, and establishes the stage of liver injury.

• #60 Alcohol-Induced Hepatitis: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17853-alcoholic-hepatitis

  If its not too far advanced, it can be reversed by quitting alcohol. Those who dont quit will continue to progress toward cirrhosis and liver failure. Existing scar tissue in your liver cant be reversed, but you can still prevent further damage and preserve the rest of your liver by quitting. […] People who quit drinking alcohol after diagnosis show great improvement after six to 12 months. Milder cases often resolve completely. More severe cases can continue to show gradual improvement over the following years. […] If you dont stop drinking after diagnosis, you have a reduced life expectancy. For men who dont stop drinking, the five-year survival rate is about 70%. For women who dont stop drinking, its 30%. […] Alcohol-induced hepatitis begins quietly, often without symptoms. Many people fail to recognize the damage that chronic heavy drinking may be doing to their livers. But early recognition is your best hope of catching and reversing the effects of alcohol-induced hepatitis.

• #61

  https://www.nhs.uk/conditions/alcohol-related-liver-disease-arld/

  Alcoholic hepatitis, which is unrelated to infectious hepatitis, is a potentially serious condition that can be caused by alcohol misuse over a longer period. […] The liver damage associated with mild alcoholic hepatitis is usually reversible if you stop drinking permanently. […] Severe alcoholic hepatitis, however, is a serious and life-threatening illness. […] Many people die from the condition each year in the UK, and some people only find out they have liver damage when their condition reaches this stage.

• #62 Alcoholic Liver Disease | Cleveland Clinic

  https://my.clevelandclinic.org/departments/digestive/medical-professionals/hepatology/alcoholic-liver-disease

  The diagnosis of alcoholic cirrhosis rests on finding the classic signs and symptoms of end-stage liver disease in a patient with a history of significant alcohol intake. […] The overall clinical diagnosis of alcoholic liver disease, using a combination of physical findings, laboratory values, and clinical acumen, is relatively accurate. […] However, liver biopsy can be justified in selected cases, especially when the diagnosis is in question.

• #63 Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis – Sharma – Translational Gastroenterology and Hepatology

  https://tgh.amegroups.org/article/view/5544/html

  The diagnosis of ALD is made based on reliable history of significant alcohol intake, clinical examination and laboratory features suggestive of significant alcohol intake. […] However reliable history of significant alcohol intake is clinically challenging in many patients and making a diagnosis of ALD need assessment by screening tools and laboratory tests. […] No single laboratory or imaging study can confirm the diagnosis of ALD. […] In outpatient or inpatient department a diagnosis of ALD should be suspected in patients with a significant alcohol abuse who present with abnormal serum transaminases, level of aspartate aminotransferase (AST) which is greater than that of alanine aminotransferase (ALT), clinical finding of hepatomegaly with signs of chronic liver disease, and radiological evidence of liver steatosis or fibrosis/cirrhosis.

• #64 Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis – Sharma – Translational Gastroenterology and Hepatology

  https://tgh.amegroups.org/article/view/5544/html

  Liver biopsy if done shows macrovesicular steatosis, fibrosis or cirrhosis or combination of these findings. […] The diagnosis of AH can be made with good sensitivity and specificity thorough good reliable history, physical examination, and laboratory results. […] Liver biopsy is confirmatory if diagnosis is in doubt, but generally not required in day to day management of these patients. […] Liver biopsy will show neutrophil predominant inflammatory infiltrate, Mallory hyaline, ballooned hepatocytes and varied degree of fibrosis or cirrhosis as overlap of these pathological findings are common. […] Liver biopsy is normally not required for the confirmation of alcoholic cirrhosis. […] However, if there is any doubt, no definitive history of significant alcohol intake in the recent past, associated AH which require steroid treatment or associated co infection with viral disease, one may need to do transjugular liver biopsy for proper evaluation of aetiology of liver cirrhosis. […] Liver biopsy is generally not required in majority of patients except when history of alcohol intake is not reliable, associated infection with viral disease, obesity or other hepatotropic or non-hepatotropic insult and treatment protocols under trials when definitive diagnosis of AH is required.

• #65 Diagnosis and treatment of alcoholic hepatitis | Frontline Gastroenterology

  https://fg.bmj.com/content/5/2/123

  Alcoholic liver disease (ALD) is increasing in incidence in the UK. Alcoholic hepatitis (AH) is an acute form of ALD with high mortality when severe. Jaundice and coagulopathy are clinical hallmarks of severe AH. Histology findings are characterised by parenchymal inflammation and hepatocellular damage although biopsy is only required when diagnostic uncertainty exists; clinical findings are usually sufficient for accurate diagnosis. Patients with AH should be stratified as non-severe or severe using non-invasive scoring systems such as the discriminant function or the Glasgow Alcoholic Hepatitis Score. […] Severe AH requires specialist treatment. Consensus guidelines recommend the use of prednisolone although this remains subject to clinical trials. […] Patients with severe disease who do not respond to therapy within a week have a very poor outcome. Recent data have shown a survival benefit of liver transplantation in this group although this remains experimental at present. Current and future research should focus on targeted therapies for severe AH and those who fail first-line treatment.

• #66 Alcoholic Hepatitis: Diagnosis and Management | AAFP

  https://www.aafp.org/pubs/afp/issues/2022/0400/p412.html

  There is growing support for early liver transplantation in some patients with severe alcoholic hepatitis, rather than requiring six months of alcohol abstinence and engagement in alcohol cessation counseling. […] Ongoing treatment of alcohol use disorder is paramount to long-term survival of patients with alcoholic hepatitis.

• #67 How Should Acute Alcoholic Hepatitis be Treated? – The Hospitalist

  https://www.the-hospitalist.org/hospitalist/article/125417/how-should-acute-alcoholic-hepatitis-be-treated/

  Alcoholic hepatitis is a severe form of alcohol-related liver disease associated with significant short-term mortality. […] The diagnosis of alcoholic hepatitis is usually made on the basis of typical clinical and laboratory features. […] Treatment should include abstinence from alcohol and supplemental nutrition in all patients with alcoholic hepatitis. […] Because of the accuracy of clinical diagnosis, biopsy is rarely required, relying instead on clinical and laboratory features for diagnosis. […] Prognosis can be determined with prediction models. […] The evidence-based literature supporting the efficacy of treatments for alcoholic hepatitis is limited, and expert opinions sometimes conflict. […] Abstinence has been shown to improve survival in all stages of alcohol-related liver disease. […] Enteral nutritional support was shown in a multicenter study to be associated with reduced infectious complications and improved one-year mortality.

Zobacz więcej